Home
Issues
Aim & Scope
Open Access
Indexing
Why publish with us
Contact
Editorial Board
Instructions to Authors (PDF)
Manuscript Types
Manuscript Formatting
How to submit
Preprints
Authorship & COI
Principles of Transparency Checklist
Publication Ethics and Publication Malpractice Statement
CrossMark
Data Policies
CASE REPORT
Skipping a single dose of mepolizumab resulted in significant clinical and functional deterioration
1
2nd Respiratory Medicine Department,
University of Athens Medical School,
Athens, Greece
Publication date: 2021-08-31
Corresponding author
Andriana I. Papaioannou
University of Athens, Athens Greece Attikon University Hospital Rimini 1 Street, Chaidari 12462, Athens Greece
University of Athens, Athens Greece Attikon University Hospital Rimini 1 Street, Chaidari 12462, Athens Greece
Pneumon 2020;33(4):205-208
KEYWORDS
ABSTRACT
Therapy with biologics is now the first choice of add on therapy in
the management of severe asthma. However, little is known about
the consequences of poor adherence to therapy on asthma control
and lung function. Here, we report a case of an asthmatic patient
with severe eosinophilic asthma whose asthma was ameliorated by
mepolizumab use and whose symptoms had worsened, and asthma
control was lost after skipping one single dose of the drug.
CONFLICTS OF INTEREST
None.
FUNDING
None.
REFERENCES (15)
1.
GINA Difficult to treat and severe asthma in adolescents and adult patients. Diagnosis and management 2019.
2.
Moraitaki P, Papamichail D, Georgatou N. Severe Asthma: Definitions, risk factors and phenotype characterization. Pneumon 2010; 23:276-92.
3.
Katsoulis K, Tryfon S. Questions and Answers about the use of omalizumab in clinical practice. Pneumon 2017; 30:92-6.
4.
Global Initiative for Asthma 2017: Updated from Global Strategy for Asthma Management and Prevention. Workshop Report 2017. Available at www.ginasthma.com. 2017.
5.
Hart TK, Cook RM, Zia-Amirhosseini P, et al. Preclinical efficacy and safety of mepolizumab (SB-240563), a humanized monoclonal antibody to IL-5, in cynomolgus monkeys. J Allergy Clin Immunol 2001; 108:250-7.
6.
Roufosse F. Targeting the Interleukin-5 Pathway for Treatment of Eosinophilic Conditions Other than Asthma. Front Med (Lausanne) 2018; 5:49.
7.
Ortega HG, Liu MC, Pavord ID, et al. Mepolizumab treatment in patients with severe eosinophilic asthma. N Engl J Med 2014; 371:1198-207.
8.
Pavord ID, Korn S, Howarth P, et al. Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial. Lancet 2012; 380:651-9.
9.
Bel EH, Wenzel SE, Thompson PJ, et al. Oral glucocorticoidsparing effect of mepolizumab in eosinophilic asthma. N Engl J Med 2014; 371:1189-97.
10.
Haldar P, Brightling CE, Singapuri A, et al. Outcomes after cessation of mepolizumab therapy in severe eosinophilic asthma: a 12-month follow-up analysis. J Allergy Clin Immunol 2014; 133:921-3.
11.
Bagnasco D, Aloe T, Sclifo F, et al. When to stop biologicals. Severe asthma exacerbation after mepolizumab discontinuation. Eur Ann Allergy Clin Immunol 2019; 51:135-7.
12.
Smith IJ, Bell J, Bowman N, Everard M, Stein S, Weers JG. Inhaler devices: what remains to be done? J Aerosol Med Pulm Drug Deliv 2010; 23 Suppl 2: S25-37.
13.
Reddel HK, Bateman ED, Becker A, et al. A summary of the new GINA strategy: a roadmap to asthma control. Eur Respir J 2015; 46:622-39.
14.
Bel EH, Bernstein DI, Bjermer L, et al. Usability of mepolizumab single-use prefilled syringe for patient self-administration. J Asthma 2019:1-10.
15.
Bernstein D, Pavord ID, Chapman KR, et al. Usability of mepolizumab single-use prefilled autoinjector for patient selfadministration. J Asthma 2019:1-12.
Share
RELATED ARTICLE
| eISSN: | 1791-4914 |
| ISSN: | 1105-848X |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
